Brand

Granules Pharmaceuticals Inc. Recalls

11 recalls on record. Search official CPSC, FDA, and USDA datasets for every recall issued for Granules Pharmaceuticals Inc..

11Total Recalls
0Critical
642,886Units Affected
Jan 26, 2026Most Recent
All Recalls

Every Granules Pharmaceuticals Inc. Recall

Sorted by most recent. Click any recall for full details.

11 recalls
High RiskFDA
Granules Pharmaceuticals Inc.
Trazodone Hydrochloride, USP, 50 mg, 100-Count Bottle, Rx only, Manufactured by: Granules India Limited, Hyderabad, 500 081, India, Manuf...
Drugs·71,424 affected·Jan 26, 2026
RecallFDA
Granules Pharmaceuticals Inc.
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Caps...
Oral Drugs·11,909 affected·Aug 28, 2025
RecallFDA
Granules Pharmaceuticals Inc.
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Caps...
Oral Drugs·11,895 affected·Aug 28, 2025
RecallFDA
Granules Pharmaceuticals Inc.
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Caps...
Oral Drugs·3,384 affected·Aug 28, 2025
RecallFDA
Granules Pharmaceuticals Inc.
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Caps...
Oral Drugs·9,917 affected·Aug 28, 2025
RecallFDA
Granules Pharmaceuticals Inc.
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Caps...
Oral Drugs·11,928 affected·Aug 28, 2025
High RiskFDA
Granules Pharmaceuticals Inc.
Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-count bottle, NDC 70...
Oral Drugs·27,648 affected·Jun 24, 2025
High RiskFDA
Granules Pharmaceuticals Inc.
Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 1000-count bottles, Rx Only, Manufactured by: Granules India Limited, Hyde...
Oral Drugs·6,804 affected·Dec 30, 2024
High RiskFDA
Granules Pharmaceuticals Inc.
Colchicine Capsules 0.6 mg, 30-count bottles, Rx only, Manufactured by: Granules Pharmaceuticals Inc. Chantilly, VA 20151 NDC 70010-001-03
Oral Drugs·96 affected·Dec 18, 2024
High RiskFDA
Granules Pharmaceuticals Inc.
Gabapentin Tablets, USP, 600 mg, 500-count bottles, Rx only, Manufactured by: Granules India Limited Hyderabad-500 081, India, Manufactur...
Oral Drugs·11,808 affected·Jul 31, 2024
High RiskFDA
Granules Pharmaceuticals Inc
Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, a) 100 ct. bottle (NDC 70010-492-01) and 500 ct. bottle (NDC 70010-492-05),...
Oral Drugs·476,073 affected·Jul 3, 2020